Page 15 - Phd Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wasatch Micro Cap Fund’s Q1 Top Detractor: Frequency Therapeutics Inc. (FREQ) Wasatch Global Investors, an investment management firm, published its “Wasatch Micro Cap Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.95% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell Microcap Index, which rose 23.89% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021. Wasatch Micro Cap, in its Q1 2021 investor letter, mentioned Frequency Therapeutics, Inc. (NASDAQ: FREQ)...

Here’s Why Artisan Partners Disposed its Sarepta Therapeutics Inc. (SRPT) Position Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded here. A return of -2.36% was recorded by its Investor Class: ARTMX, -2.32% by its Advisor Class: APDMX, and -2.30% by its Institutional Class: APHMX, in the fourth quarter of 2020, all below the Russell Midcap® Growth Index that delivered a -0.57% return and the Russell Midcap® Index that was up by 8.14% for the same period. You c...

Alger Small Cap on Berkeley Lights (BLI): “We Believe the Base Business Remains Strong” Alger, an investment management firm, published its “Alger Small Cap Focus Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.  During the quarter, the largest portfolio sector weightings were Health Care and Information Technology. The largest sector overweight was Health Care. Class A shares of the Alger Small Cap Focus Fund underperformed the Russell 2000 Growth Index during the first quarter of 2021. You can view the fund’s top 5 holdings to have a peek at th...

Is Valhi Inc. (VHI) A Smart Long-Term Buy? East 72, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be downloaded here.  A quarterly portfolio return of 9.1% was recorded by the fund for the Q1 of 2021. Over the year to March 31, 2021, East 72 returned 42.7% before expenses, despite an average net equity exposure of only 28%. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021. East 72, in their Q1 2021 investor letter, mentioned Valhi, Inc. (NYSE: VHI) and shared their insights on the company. Valhi, Inc....

Is It Too Late to Buy Biogen (BIIB) Stock? Del Principe O’Brien Financial Advisors recently released its March 2021 investor letter – a copy of which is available for download here. You should check out Del Principe O’Brien Financial Advisors top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021. In the Q4 2020 Investor Letter, the fund highlighted a few stocks and Biogen Inc. (NASDAQ:BIIB) is one of them. Biogen Inc. (NASDAQ:BIIB) is a biotechnology company. In the last three months, Biogen Inc. (NASDAQ:BIIB) stock gained 6.6% and on April 7th it ...